CIK: 1178670 - Address: 300 Third Street, 3Rd Floor, Cambridge, MA 02142
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1120173597128746
S%wins40454025152031

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/24/16 18:20
2/23/16
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS-7,1807.189-1,000-174,897D-34-62-11-2542520-12-62-5-16-48-82
10/28/14 16:59
10/22/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.am-1,58514.0233-113-25,897D28215516718214918216734313-10-24-60
10/24/14 21:27
10/22/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-1,58514.0225-113-25,897D208951161238411111611366-814-19-74
10/17/14 17:37
10/15/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-826.741-1206,010D63-19-12-3-36531141531651527
10/10/14 18:25
10/8/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-666.561-1006,022D-28-161-4-7-4-3492411991728
10/3/14 17:19
10/1/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-696.741-1006,032D-29-13-16-1-14-3-4-2-5192151139-6
9/26/14 17:37
9/24/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-627.131-906,042D-25-20-12-1-1-510-41451091384
9/19/14 17:09
9/17/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-567.310-806,051D-18-29-11108-2-2-20-511515329
9/12/14 18:24
9/10/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-707.850-906,059D-16-25102616148-4-7-1910313913
9/5/14 18:52
9/3/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-717.070-1006,068D-24-3266134413-314219019
8/29/14 19:12
8/27/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-357.000-506,078D-28-39100-8-224417217220
8/22/14 19:23
8/20/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-746.890-1106,083D-25-3511611-1-520213717116
8/15/14 19:12
8/13/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-387.010-506,093D-21-2411-139004-271781394
8/8/14 20:08
8/6/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-526.870-806,099D-30-2016-16-1314491811503
8/1/14 18:52
7/30/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-346.350-506,106D-37-31-12-23-2-73781118620331
7/25/14 20:40
7/23/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-356.751-506,112D-35-19-6-7-1721-4-2410717839
7/18/14 19:17
7/16/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-906.661-1406,117D-32-12-5-2-17-80-104-315153
7/11/14 20:25
7/9/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-546.731-806,131D-45-7-20-5-21-18-11225720055
7/7/14 17:19
7/2/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-358.071-406,139D-24104301341-3-10-9-612137
6/27/14 18:45
6/25/14
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAlnylam Pharmaceuticals, Inc.MATS.m-607.880-806,143D-133-92516-1123-20-118730

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact